ID   OV-MZ-6#8-BAG
AC   CVCL_F1AW
RX   PubMed=12297307;
CC   Characteristics: Can be stained with the L-galactosidase substrate 5-bromo-4-chloro-3-indolyl L-D-galactoside (X-Gal) in order to follow spreading of tumors in in-vivo models (PubMed=12297307).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X988 ! OV-MZ-6#8
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
RX   PubMed=12297307; DOI=10.1016/S0014-5793(02)03311-2;
RA   Sato, Sumito
RA   Kopitz, Charlotte
RA   Schmalix, Wolfgang A.
RA   Muehlenweg, Bernd
RA   Kessler, Horst
RA   Schmitt, Manfred
RA   Kruger, Achim
RA   Magdolen, Viktor
RT   "High-affinity urokinase-derived cyclic peptides inhibiting
RT   urokinase/urokinase receptor-interaction: effects on tumor growth and
RT   spread.";
RL   FEBS Lett. 528:212-216(2002).
//